Nussbaumer-Streit B, Winkler D, Spies M, Kasper S, Pjrek E
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Department for Evidence-based Medicine and Clinical Epidemiology, Danube-University Krems, Dr.-Karl-Dorrek Strasse 30, 3500, Krems a.d. Donau, Austria.
BMC Psychiatry. 2017 Jul 11;17(1):247. doi: 10.1186/s12888-017-1403-2.
Seasonal affective disorder (SAD) is a seasonally recurrent type of major depression. This predictable aspect makes it promising for preventive treatment. However, evidence for the efficacy and harm of preventive treatment of SAD is scarce, as are recommendations from clinical practice guidelines. The aim of this study was to assess the current use of preventive treatment of SAD in clinical practice in German-speaking countries for the first time.
We conducted a postal and web-based survey sent to the heads of all psychiatric institutions listed in the inventory "Deutsches Krankenhaus Adressbuch, 2015" that contains all psychiatric hospitals in Germany, Austria, and Switzerland.
One hundred institutions (out of 533 institutions, 19%), which treated in total more than 3100 SAD patients in the years 2014/2015, responded. Of those, 81 reported recommending preventive treatment to patients with a history of SAD. There was no consensus on the optimal starting point for preventive treatment. Most of the institutions that implemented prevention of SAD, recommended lifestyle changes (85%), antidepressants (84%), psychotherapy (73%), and light therapy (72%) to their patients. The situation was similar in northern and southern regions.
Most hospitals recommended the use of preventive treatment to SAD patients, although evidence on efficacy and harm is limited. A wide variety of interventions were recommended, although guidelines only include recommendations for acute treatment. To assist psychiatrists and patients in future decision making, controlled studies on preventive treatment for SAD that compare different interventions with one another are needed.
季节性情感障碍(SAD)是一种季节性复发的重度抑郁症。这种可预测性使其在预防性治疗方面具有前景。然而,关于SAD预防性治疗的疗效和危害的证据稀少,临床实践指南中的相关建议也同样如此。本研究的目的是首次评估德语国家临床实践中SAD预防性治疗的当前使用情况。
我们向“2015年德国医院通讯录”中列出的所有精神科机构负责人进行了邮寄和网络调查,该通讯录包含德国、奥地利和瑞士的所有精神病医院。
533家机构中有100家(19%)做出回应,这些机构在2014/2015年共治疗了3100多名SAD患者。其中,81家报告向有SAD病史的患者推荐预防性治疗。对于预防性治疗的最佳起始点没有达成共识。大多数实施SAD预防的机构向患者推荐生活方式改变(85%)、抗抑郁药(84%)、心理治疗(73%)和光疗(72%)。北部和南部地区的情况类似。
大多数医院向SAD患者推荐使用预防性治疗,尽管疗效和危害的证据有限。推荐了多种干预措施,尽管指南仅包括急性治疗的建议。为了帮助精神科医生和患者在未来做出决策,需要对SAD预防性治疗进行对照研究,比较不同干预措施之间的效果。